Evidence map›Paper›PMID 31240737›Full record

ArticleJournal of inherited metabolic disease2019

Analysis of the Qatari R336C cystathionine β-synthase protein in mice.

Sapna Gupta, Lorena Gallego-Villar, Liqun Wang, Hyung-Ok Lee, Gheyath Nasrallah, Nader Al-Dewik, Johannes Häberle, Beat Thöny, Henk J Blom, Tawfeg Ben-Omran and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of inherited metabolic disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 5 countries.

Sapna GuptaCancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Lorena Gallego-VillarDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University Medical Centre Freiburg, Freiburg, Germany.
Liqun WangCancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Hyung-Ok LeeCancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Gheyath NasrallahDepartment of Biomedical Sciences, College of Health Sciences and Biomedical Research Center, Qatar University, Doha, Qatar.
Nader Al-DewikClinical and Metabolic Genetics, Department of Pediatrics, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Johannes HäberleDivision of Metabolism, University Children's Hospital and Children's Research Center, Zurich, Switzerland.
Beat ThönyDivision of Metabolism, University Children's Hospital and Children's Research Center, Zurich, Switzerland.
Henk J BlomDepartment of Internal Medicine, VU University Medical Centre, Amsterdam, The Netherlands.
Tawfeg Ben-OmranClinical and Metabolic Genetics, Department of Pediatrics, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Warren D KrugerCancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.ORCID 0000-0002-4990-3695
Fox Chase Cancer Center · USHamad General Hospital · QAUniversity Children's Hospital Zurich · CHAmsterdam UMC Location Vrije Universiteit Amsterdam · NLQatar University · QAUniversity Medical Center Freiburg · DE

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
GENETIC MODULATION OF CBS TO LOWER PLASMA HOMOCYSTEINER01HL057299 · NHLBI · FOX CHASE CANCER CENTER · PI KRUGER, WARREN D · 2001 to 2009
$3.2M
Treatment of CBS Deficiency with Proteostasis ModulatorsR01DK101404 · NIDDK · RESEARCH INST OF FOX CHASE CAN CTR · PI KRUGER, WARREN D · 2014 to 2020
$3.0M
NCI NIH HHS P30 CA006927NHLBI NIH HHS R01 HL057299NIDDK NIH HHS R01 DK101404NIH HHS P30 CA006927NIH HHS R01 DK101404
6 · The paper itself

Abstract

Classical homocystinuria is a recessive inborn error of metabolism caused by mutations in the cystathionine beta-synthase (CBS) gene. The highest incidence of CBS deficiency in the world is found in the country of Qatar due to the combination of high rates of consanguinity and the presence of a founder mutation, c.1006C>T (p.R336C). This mutation does not respond to pyridoxine and is considered severe. Here we describe the creation of a mouse that is null for the mouse Cbs gene and expresses human p.R336C CBS from a zinc-inducible transgene (Tg-R336C Cbs

Indexed as

AllelesAnimalsBortezomibCystathionine beta-SynthaseDNA Mutational AnalysisFemaleHomocysteineHomocystinuriaMaleMiceMice, Inbred C3HMice, Inbred C57BLMice, KnockoutMutationProteasome InhibitorsPyridoxineBortezomibCystathionine beta-SynthaseHomocysteineProteasome InhibitorsPyridoxinehomocysteineinborn errormetabolismmethioninemissense mutationmouse model

Identifiers

PMID31240737
PMCPMC7336392
OpenAlexW2953624658

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.